Navigation Links
Anti-cancer drug prevents, reverses cardiovascular damage in mouse model of premature aging disorder
Date:10/6/2008

An experimental anti-cancer drug can prevent -- and even reverse -- potentially fatal cardiovascular damage in a mouse model of progeria, a rare genetic disorder that causes the most dramatic form of human premature aging, National Institutes of Health (NIH) researchers reported today.

In a study published in the Oct. 6 early online edition of the Proceedings of the National Academy of Sciences, a team led by Francis S. Collins, M.D., Ph.D., of the National Human Genome Research Institute (NHGRI), and Elizabeth G. Nabel, M.D., director of the National Heart, Lung and Blood Institute (NHLBI), describes its effort to use transgenic mice to identify and test potential therapies for children with Hutchinson-Gilford progeria syndrome.

There currently are no treatments for progeria, which is estimated to affect about one child in 4 million. At birth, children with progeria appear normal. But soon growth slows, and the children begin to show signs of accelerated aging, such as hair loss, wrinkled skin and loss of body fat. The most lethal damage, however, occurs within the children's major blood vessels. The children develop premature cardiovascular disease, which typically leads to death from heart attack or stroke at about the age of 13.

Building upon its past experiments in cells and mice, the NIH-led team examined the effects of an experimental cancer drug, tipifarnib, in a strain of mice genetically engineered to develop cardiovascular damage similar to that seen in progeria patients. Tipifarnib belongs to a class of drugs known as farnesyltransferase inhibitors (FTIs), which are being tested in people with myeloid leukemia, neurofibromatosis and other conditions. The team had previously found that FTI drugs could reverse structural abnormalities in skin cells taken from progeria patients and grown in the laboratory.

"This approach worked much better than we thought it would. Not only did this drug prevent these mi
'/>"/>

Contact: Geoff Spencer
spencerg@mail.nih.gov
301-402-0911
NIH/National Human Genome Research Institute
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
2. Novel anti-cancer mechanism found in long-lived rodents
3. Gene therapy anti-cancer research featured in Scientific American
4. Drug reverses mental retardation caused by genetic disorder
5. Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice
6. New discoveries from Harvard and Baylor get to the heart of cardiovascular disease
7. Gladstone and Izumi Bio in partnership in regenerative medicine and cardiovascular disease
8. New research shows no link between aromatase inhibitors and cardiovascular problems
9. Genetic variants of USF1 are associated with the increased risk for cardiovascular disease
10. Cell Therapy for Cardiovascular Diseases
11. Medical breakthrough for organ transplants and cardiovascular diseases by Flemish researchers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...nce is opening new doors to understanding how soun...ring of a marine mammal or if they hear it at all...y scanners that NASA uses to detect flaws in the s...allowing scientists to peek inside the giant head ...-dimensional replicas of a whale,s hearing anatomy...
(Date:11/24/2009)...level action of a remarkable class of ring-shaped ...ith the Lawrence Berkeley National Laboratory (Ber...llography beamline at the Advanced Light Source (A...ne expression and replication, and are vital to th...ectious agents, such as the human papillomavirus, ...
(Date:11/24/2009)...GE Antarctica has long held secrets of the earth,...ntly, there has been very little information on th... of ice for millions of years. Now, a team of rese...e been funded to the tune of $10 million dollars b...to the bottom of things literally. These scientis...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4LSU gets to the bottom of things -- in Antarctica 2Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 1Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 2LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 1LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 2SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 1SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 2SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 3SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 4SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 5
...h project supported by the BBVA Foundation and led...lied Bioacoustics at the UPC (Universitat Politcni...ortable system for measuring cetacean hearing sens...litates in situ diagnosis of cetacean hearing loss...hances of stranded animals without having to trans...
...uing cleaner energy there is such a thing as being... can be considered too green. In a paper in a spec...Society,s (OSA) open-access journal, scientists at... method for using microalgae for making biofuel. T... the tiny organisms, so as to minimize the number ...
... Beckman Coulter,Inc. (NYSE: BEC ), a leading de...t simplify, automate and innovate complex biomedic...eliminary 2009 financial outlook. , (Logo: ...GO ) , Scott Garrett, chairman, president and ch...mic uncertainties, we remain confident about achie...
Other Biology News:A BBVA Foundation project comes up with a system enabling detection of cetacean hearing loss 2A BBVA Foundation project comes up with a system enabling detection of cetacean hearing loss 3Engineering algae to make fuel instead of sugar 2Beckman Coulter Updates 2008 Outlook 2Beckman Coulter Updates 2008 Outlook 3Beckman Coulter Updates 2008 Outlook 4Beckman Coulter Updates 2008 Outlook 5
(Date:11/25/2009)... Ambassador to Speak at Economic Club of ...(Vocus) November 25, 2009 -- Ambassador to Speak a...pia, French Ambassador for International Investmen...ency ,To view a biography of David Appia go to ww...ia is available to meet with press to discuss rece...
(Date:11/25/2009)...Nov.25/PRNewswire/--Reportlinker.comannouncesthata...,, BrazilBioethanolMarketAnalysisandForecastst.../Brazil-Bioethanol-Market-Analysis-and-Forecasts-t...ndForecaststo2013 ,, Summary ,, Thereportp...thanolmarketandtheBrazilbioethanolmarketinparticul...
(Date:11/24/2009)... Ambassador to also Visit Detroit , ... , ,Who: David Appia, French Ambassador for Intern...vest in France Agency, , , , ,What: Ambassador Ap...ent pro-business initiatives adopted by France to ... landscape for innovation and development., , ,Whe...
(Date:11/24/2009)...K,Iceland,November24/PRNewswire-FirstCall/--deCODE...asreceivednoticefrom,theNasdaqStockMarketthattradi...ember30,2009andaForm25-NSEwillbefiledwiththe,Secur...commonstock,fromlistingonNasdaq,unlessthecompanyfi...Thecompanyhasfiledsuchanappeal,which,willstaythesu...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
... Sequence information from the completed human ge...f the human genome. Empowered by the expanded avai...ave become an increasingly effective tool for iden...ity. , Physical differences between indivi... genetic studies is to identify specific genetic p...
... , Overview: , One of the ma...n serum is the dynamic range of the concentrations...m albumin (HSA) constitutes 57-71% of total serum ...8-26%. Removal of these two proteins alone clears ...hereby allowing the enhanced detection of the rema...
... Purpose , This application note descr...h Metabolite ID software for Phase I and Phase II ... capabilities that increase your productivity and ..., Current trends in drug development are p...ial drug candidates earlier in the discovery proce...
Other Biology Technology:SNPs Powerful Tools for Association Studies 2SNPs Powerful Tools for Association Studies 3SNPs Powerful Tools for Association Studies 4SNPs Powerful Tools for Association Studies 5SNPs Powerful Tools for Association Studies 6SNPs Powerful Tools for Association Studies 7SNPs Powerful Tools for Association Studies 8SNPs Powerful Tools for Association Studies 9SNPs Powerful Tools for Association Studies 10SNPs Powerful Tools for Association Studies 11SNPs Powerful Tools for Association Studies 12SNPs Powerful Tools for Association Studies 13SNPs Powerful Tools for Association Studies 14SNPs Powerful Tools for Association Studies 15SNPs Powerful Tools for Association Studies 16SNPs Powerful Tools for Association Studies 17SNPs Powerful Tools for Association Studies 18SNPs Powerful Tools for Association Studies 19Affinity Depletion Cartridges for Removal of Human Serum Albumin and Immunoglobulins from Human Serum 2Affinity Depletion Cartridges for Removal of Human Serum Albumin and Immunoglobulins from Human Serum 3Affinity Depletion Cartridges for Removal of Human Serum Albumin and Immunoglobulins from Human Serum 4Affinity Depletion Cartridges for Removal of Human Serum Albumin and Immunoglobulins from Human Serum 5Identification of Phase I and Phase II Metabolites of Buspirone on the Q TRAP LC/MS/MS System 2Identification of Phase I and Phase II Metabolites of Buspirone on the Q TRAP LC/MS/MS System 3Identification of Phase I and Phase II Metabolites of Buspirone on the Q TRAP LC/MS/MS System 4Identification of Phase I and Phase II Metabolites of Buspirone on the Q TRAP LC/MS/MS System 5
...l to BRF2 Immunogen Synthetic peptide: QAARQAATS...-419 of Human BRF2. Reactivity / Specificity Cro...ies. Background Information BRF2 is one of the m...iption factor complex required for transcription o...
Kinase Buffer (10X) from Cell Signaling Technology
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Biology Products: